Lamivudine (WHOAPI-428) manufactured by Styrax Life Sciences Pvt Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
The World Health Organization (WHO), through its Prequalification Unit and Global Tuberculosis Programme, would like to announce that the transition period for WHO procurement el
Rifampicin (WHOAPI-507) manufactured by Macleods Pharmaceuticals Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
The Invitation to Manufacturers for HIV Infections and Related Diseases to submit an Expression of Interest for Product E
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
On 29 October 2024, the revised 9th NTD EOI, now including Moxidectin, was published.
On 8 October 2024, WHO granted prequalification for the age-extension of the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine for use in adolescents aged 12 to 17 years, expanding its indi
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
On 14 October 2024 WHO listed the second mpox IVD under the WHO Emergency Use Listing (EUL) procedure.
WHO is seeking for public comments on a new proposed version of the Guidance on reportable changes to IVDs (deadline for submission of comments by 15 November 2024).
Dolutegravir (sodium) manufactured by Aurore Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
The PQT Medicines 7th Annual Medicines Quality Workshop for Manufacturers will take place from 23 to 26 September 2024.
Molnupiravir manufactured by Aurore Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Tranexamic acid manufactured by Ami Lifesciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
10 July 2024 – The World Health Organization (WHO) has preq
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
A webinar for IVD manufacturers was held on 26 June.